The global patient monitoring devices market size was USD 44.44 billion in 2023, calculated at USD 48.18 billion in 2024 and is projected to surpass around USD 107.93 billion by 2034, expanding at a CAGR of 8.4% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Patient Monitoring Devices Market, by Product Type, 2024-2034
7.1.1. Cardiac Monitoring Devices
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Blood Glucose Monitoring Systems
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Multi-parameter Monitoring Devices
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Temperature Monitoring Devices
7.1.4.1. Market Revenue and Forecast (2021-2034)
7.1.5. Respiratory Monitoring Devices
7.1.5.1. Market Revenue and Forecast (2021-2034)
7.1.6. Hemodynamic/Pressure Monitoring Devices
7.1.6.1. Market Revenue and Forecast (2021-2034)
7.1.7. Fetal & Neonatal Monitoring Devices
7.1.7.1. Market Revenue and Forecast (2021-2034)
7.1.8. Neuromonitoring Devices
7.1.8.1. Market Revenue and Forecast (2021-2034)
7.1.9. Weight Monitoring Devices
7.1.9.1. Market Revenue and Forecast (2021-2034)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2021-2034)
8.1. Patient Monitoring Devices Market, by End-use, 2024-2034
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Home Care Settings
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Ambulatory Surgery Centers
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.2. Market Revenue and Forecast, by End-use (2021-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.4.2. Market Revenue and Forecast, by End-use (2021-2034)
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Hill-Rom Holdings, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Drägerwerk AG & Co. KGaA
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Edwards Lifesciences Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. OMRON Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Masimo Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Compumedics Limited
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Nihon Kohden Corporation
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Natus Medical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample